Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 13 Pancreatic Neoplasms 3 Carcinoma, Renal Cell 3 Breast Neoplasms 3 Sarcoma, Ewing 2 Ovarian Neoplasms 2 Neoplasm Metastasis 2 Colorectal Neoplasms 2 Wilms Tumor 1 Triple Negative Breast Neoplasms 1 Stomach Neoplasms 1 Small Cell Lung Carcinoma 1 Sarcoma 1 Rhabdomyosarcoma 1 Rhabdoid Tumor 1 Prostatic Diseases 1 Prostate Cancer Metastatic 1 Osteosarcoma 1 Neuroectodermal Tumors, Primitive, Peripheral 1 Neuroblastoma 1 Neoplasms 1 Metastatic Castration Resistant Prostate Cancer (mCRPC) 1 Kidney Neoplasms 1 Hepatoblastoma 1 Fanconi Anemia, Complementation Group D1 1 Carcinoma, Transitional Cell 1 Carcinoma, Ovarian Epithelial 1 Adenocarcinoma 1

Interventions

pembrolizumab 6 Radiosurgery 5 Docetaxel 5 enzalutamide 4 darolutamide 3 Radiotherapy 3 Everolimus 3 Androgen Antagonists 3 relugolix 2 luprolide acetate gel depot 2 Surveys and Questionnaires 2 Standard of Care 2 Radiotherapy, Image-Guided 2 Radiofrequency Ablation 2 Panobinostat 2 Leuprolide 2 Abiraterone Acetate 2 trastuzumab deruxtecan 1 talazoparib 1 spartalizumab 1 siremadlin 1 sipuleucel-T 1 sargramostim 1 resiquimod 1 polysaccharide-K 1 poly ICLC 1 palbociclib 1 olaparib 1 liposomal doxorubicin 1 ixabepilone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Adenocarcinoma × talazoparib × Genitourinary × Clear all

NCT06844383 2026-04-24

TALENT

Prostate Cancer Clinical Trials Consortium

Phase 2 Recruiting

Adenocarcinoma, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡